Kimitaka Takitani
Kimitaka Takitani has a total of 24 co-authors. Here are the top co-authors by number of shared publications:
Hiroshi Tamai
Department of Pediatrics, Osaka Medical College, 2-7 Daigakumachi, Takatsuki-shi, Osaka 569-8686, Japan
12 shared publicationsHiroshi Miyazaki
Department of Pediatrics, Osaka Rosai Hospital, 1179-3 Nagasonecho, Kita-ku, Sakai-shi, Osaka 591-8025, Japan
8 shared publicationsMaki Koh
Department of Pediatrics, Osaka Medical College, 2-7 Daigakumachi, Takatsuki-shi, Osaka 569-8686, Japan
7 shared publicationsAkiko Inoue
Department of Pediatrics, Osaka Medical College, 2-7 Daigakumachi, Takatsuki-shi, Osaka 569-8686, Japan
6 shared publicationsAtsushi Yoden
Department of Pediatrics, Osaka Medical College, 2-7 Daigakumachi, Takatsuki, Osaka 569-8686, Japan
4 shared publicationsKanta Kishi
Department of Pediatrics, Osaka Medical College, 2-7 Daigakumachi, Takatsuki-shi, Osaka 569-8686, Japan
3 shared publications
Latest Publications
- Open Access
- 1 January 2015
- Published by The Society for Free Radical Research Japan in Journal of Clinical Biochemistry and Nutrition
- Vol. 56 (3) , 195-200
Altered retinol status and expression of retinol-related proteins in streptozotocin-induced type 1 diabetic model rats
Diabetes is a metabolic disorder characterized by chronic hyperglycemia. Advanced diabetes is associated with severe complications and impaired nutritional status. Here, we assessed the expression of retinol-associated proteins, including beta-carotene 15,15'-monooxygenase (BCMO), lecithin:retinol acyltransferase (LRAT), aldehyde dehydrogenase (ALDH), and cytochrome P450 26A1 (CYP26A1), and measured retinol levels in the plasma and liver of streptozotocin (STZ)-induced type 1 diabetic model rats. Compared to the levels in the control rats, retinol levels in the plasma and liver of STZ rats were decreased and increased, respectively. Hepatic expression of the LRAT gene in STZ rats was lower than that in the controls. In the liver of STZ rats, the expression of ALDH1A1, a retinal metabolizing enzyme was higher, whereas ALDH1A2 expression was lower than in the controls. Hepatic CYP26A1 expression in STZ rats was significantly higher than in the control rats. BCMO expression levels in the liver and intestine of STZ rats were much lower than those of the controls. Altered BCMO expression might affect retinol status. It is considered that the metabolic availability of retinol was lessened despite the accelerated catabolism of retinol; therefore, retinol mobilization may be unbalanced in the liver of rats in the type 1 diabetic state.
- 1 January 2015
- Published by The Society for Free Radical Research Japan in Journal of Clinical Biochemistry and Nutrition
- Vol. 56 (3) , 195-200
Open AccessAltered retinol status and expression of retinol-related proteins in streptozotocin-induced type 1 diabetic model rats
Diabetes is a metabolic disorder characterized by chronic hyperglycemia. Advanced diabetes is associated with severe complications and impaired nutritional status. Here, we assessed the expression of retinol-associated proteins, including beta-carotene 15,15'-monooxygenase (BCMO), lecithin:retinol acyltransferase (LRAT), aldehyde dehydrogenase (ALDH), and cytochrome P450 26A1 (CYP26A1), and measured retinol levels in the plasma and liver of streptozotocin (STZ)-induced type 1 diabetic model rats. Compared to the levels in the control rats, retinol levels in the plasma and liver of STZ rats were decreased and increased, respectively. Hepatic expression of the LRAT gene in STZ rats was lower than that in the controls. In the liver of STZ rats, the expression of ALDH1A1, a retinal metabolizing enzyme was higher, whereas ALDH1A2 expression was lower than in the controls. Hepatic CYP26A1 expression in STZ rats was significantly higher than in the control rats. BCMO expression levels in the liver and intestine of STZ rats were much lower than those of the controls. Altered BCMO expression might affect retinol status. It is considered that the metabolic availability of retinol was lessened despite the accelerated catabolism of retinol; therefore, retinol mobilization may be unbalanced in the liver of rats in the type 1 diabetic state.
- 1 January 2014
- Published by Center for Academic Publications Japan in Journal of Nutritional Science and Vitaminology
- Vol. 60 (2) , 78-85
Retinol Status and Expression of Retinol-Related Proteins in Methionine-Choline Deficient Rats
Retinol and its derivative, retinoic acid, have pleiotropic functions including vision, immunity, hematopoiesis, reproduction, cell differentiation/growth, and development. Non-alcoholic fatty liver disease (NAFLD) is one of the most common diseases in developed countries and encompasses a broad spectrum of forms, ranging from steatosis to steatohepatitis, which develops further to cirrhosis. Retinol status has an important role in liver homeostasis. The purpose of this study was to evaluate the retinol status and expression of retinol-related proteins, including enzymes and binding proteins, in methionine-choline deficient (MCD) rats as a model of NAFLD. We examined retinol levels in the plasma and liver and gene expression for β-carotene 15,15′-monooxygenase (BCMO), lecithIn: retinol acyltransferase (LRAT), aldehyde dehydrogenase 1A1 (ALDH1A1), ALDH1A2, and cellular retinol binding protein (CRBP)-I in MCD rats. The plasma retinol levels in MCD rats were lower than those in the controls, whereas hepatic retinol levels in MCD rats were higher. BCMO expression in the intestine and liver in MCD rats was lower, whereas that in the testes and the kidneys was higher than in control rats. Expression of LRAT, CRBP-I, ALDH1A1, and ALDH1A2 in the liver of MCD rats was also higher. Altered expression of retinol-related proteins may affect retinol status in NAFLD.
- 1 January 2014
- Published by Center for Academic Publications Japan in Journal of Nutritional Science and Vitaminology
- Vol. 60 (2) , 78-85
Retinol Status and Expression of Retinol-Related Proteins in Methionine-Choline Deficient Rats
Retinol and its derivative, retinoic acid, have pleiotropic functions including vision, immunity, hematopoiesis, reproduction, cell differentiation/growth, and development. Non-alcoholic fatty liver disease (NAFLD) is one of the most common diseases in developed countries and encompasses a broad spectrum of forms, ranging from steatosis to steatohepatitis, which develops further to cirrhosis. Retinol status has an important role in liver homeostasis. The purpose of this study was to evaluate the retinol status and expression of retinol-related proteins, including enzymes and binding proteins, in methionine-choline deficient (MCD) rats as a model of NAFLD. We examined retinol levels in the plasma and liver and gene expression for β-carotene 15,15′-monooxygenase (BCMO), lecithIn: retinol acyltransferase (LRAT), aldehyde dehydrogenase 1A1 (ALDH1A1), ALDH1A2, and cellular retinol binding protein (CRBP)-I in MCD rats. The plasma retinol levels in MCD rats were lower than those in the controls, whereas hepatic retinol levels in MCD rats were higher. BCMO expression in the intestine and liver in MCD rats was lower, whereas that in the testes and the kidneys was higher than in control rats. Expression of LRAT, CRBP-I, ALDH1A1, and ALDH1A2 in the liver of MCD rats was also higher. Altered expression of retinol-related proteins may affect retinol status in NAFLD.
- 1 January 2014
- Published by Center for Academic Publications Japan in Journal of Nutritional Science and Vitaminology
- Vol. 60 (6) , 380-386
α-Tocopherol Status and Altered Expression of α-Tocopherol-Related Proteins in Streptozotocin-Induced Type 1 Diabetes in Rat Models
Vitamin E plays a critical role as an antioxidant in several pathological conditions, including diabetes, cancer, cardiovascular diseases, and neurodegenerative disorders. Diabetes is a metabolic disorder of glucose due to the lack of adequate insulin production (type 1) or peripheral insulin resistance (type 2). Oxidative stress plays a major role in the pathogenesis of diabetes and its complications. The purpose of the present study was to determine alpha-tocopherol status and the expression of alpha-tocopherol-related proteins, including binding proteins and metabolizing enzymes, under streptozotocin (STZ)-induced type 1 diabetes in rat models. In STZ rats, plasma alpha-tocopherol levels decreased compared to the control rats, whereas hepatic alpha-tocopherol levels in the STZ rats were significantly increased. CuZn-superoxide dismutase (SOD) gene expression in the liver of STZ rats was markedly decreased, whereas Mn-SOD gene expression remained unaltered. Accelerated lipid peroxidation in the liver of STZ rats was observed and the hepatic expression of alpha-tocopherol transfer protein (alpha-TTP) in STZ rats decreased compared to that in the controls. The hepatic expression of cytochrome P450 4F2 (CYP4F2) and CYP3A2 genes in STZ rats also decreased. The reduced expression of hepatic alpha-TTP and CYP4F2 genes probably leads to decreased plasma alpha-tocopherol levels and elevated alpha-tocopherol levels in the liver of STZ rats. The altered expression of hepatic alpha-tocopherol-related proteins might regulate alpha-tocopherol status in type 1 diabetes. Determining the mechanism of modulating alpha-tocopherol status may be helpful in promoting antioxidant therapy in diabetes.
- 1 January 2014
- Published by Center for Academic Publications Japan in Journal of Nutritional Science and Vitaminology
- Vol. 60 (6) , 380-386
α-Tocopherol Status and Altered Expression of α-Tocopherol-Related Proteins in Streptozotocin-Induced Type 1 Diabetes in Rat Models
Vitamin E plays a critical role as an antioxidant in several pathological conditions, including diabetes, cancer, cardiovascular diseases, and neurodegenerative disorders. Diabetes is a metabolic disorder of glucose due to the lack of adequate insulin production (type 1) or peripheral insulin resistance (type 2). Oxidative stress plays a major role in the pathogenesis of diabetes and its complications. The purpose of the present study was to determine alpha-tocopherol status and the expression of alpha-tocopherol-related proteins, including binding proteins and metabolizing enzymes, under streptozotocin (STZ)-induced type 1 diabetes in rat models. In STZ rats, plasma alpha-tocopherol levels decreased compared to the control rats, whereas hepatic alpha-tocopherol levels in the STZ rats were significantly increased. CuZn-superoxide dismutase (SOD) gene expression in the liver of STZ rats was markedly decreased, whereas Mn-SOD gene expression remained unaltered. Accelerated lipid peroxidation in the liver of STZ rats was observed and the hepatic expression of alpha-tocopherol transfer protein (alpha-TTP) in STZ rats decreased compared to that in the controls. The hepatic expression of cytochrome P450 4F2 (CYP4F2) and CYP3A2 genes in STZ rats also decreased. The reduced expression of hepatic alpha-TTP and CYP4F2 genes probably leads to decreased plasma alpha-tocopherol levels and elevated alpha-tocopherol levels in the liver of STZ rats. The altered expression of hepatic alpha-tocopherol-related proteins might regulate alpha-tocopherol status in type 1 diabetes. Determining the mechanism of modulating alpha-tocopherol status may be helpful in promoting antioxidant therapy in diabetes.
- Open Access
- 1 January 2014
- Published by The Society for Free Radical Research Japan in Journal of Clinical Biochemistry and Nutrition
- Vol. 54 (3) , 190-197
The α-tocopherol status and expression of α-tocopherol-related proteins in methionine-choline deficient rats treated with vitamin E
Non-alcoholic fatty liver disease is the most common liver disorder in developed countries, and its incidence is increasing in all population groups. As an antioxidant, vitamin E is effective in the treatment of non-alcoholic fatty liver disease, although the mechanism is still unclear. Methionine-choline deficient Wistar rats (n = 5) used as an experimental model of non-alcoholic fatty liver disease were fed a vitamin E-enriched diet (500 mg/kg) for 4 weeks. The effects were assessed by measuring lipid peroxidation, alpha-tocopherol levels, and the expression of alpha-tocopherol-related proteins in the liver. In vitamin E-treated methionine-choline deficient rats, lipid peroxidation was reduced, but liver histopathological changes were not improved. Hepatic alpha-tocopherol levels in these rats were significantly elevated compared to normal rats treated with vitamin E. Expression of liver alpha-tocopherol transfer protein in vitamin E-treated methionine-choline deficient rats was significantly repressed compared to methionine-choline deficient rats. The expression of liver cytochrome P450 4F2 and ATP-binding cassette transporter protein 1, involved in metabolism and transport of alpha-tocopherol, respectively, was significantly repressed in vitamin E-treated methionine-choline deficient rats. In methionine-choline deficient rats, vitamin E treatment altered the hepatic alpha-tocopherol-related protein expression, which may affect alpha-tocopherol status in the liver, leading to reduced lipid peroxidation.
- 1 January 2014
- Published by The Society for Free Radical Research Japan in Journal of Clinical Biochemistry and Nutrition
- Vol. 54 (3) , 190-197
Open AccessThe α-tocopherol status and expression of α-tocopherol-related proteins in methionine-choline deficient rats treated with vitamin E
Non-alcoholic fatty liver disease is the most common liver disorder in developed countries, and its incidence is increasing in all population groups. As an antioxidant, vitamin E is effective in the treatment of non-alcoholic fatty liver disease, although the mechanism is still unclear. Methionine-choline deficient Wistar rats (n = 5) used as an experimental model of non-alcoholic fatty liver disease were fed a vitamin E-enriched diet (500 mg/kg) for 4 weeks. The effects were assessed by measuring lipid peroxidation, alpha-tocopherol levels, and the expression of alpha-tocopherol-related proteins in the liver. In vitamin E-treated methionine-choline deficient rats, lipid peroxidation was reduced, but liver histopathological changes were not improved. Hepatic alpha-tocopherol levels in these rats were significantly elevated compared to normal rats treated with vitamin E. Expression of liver alpha-tocopherol transfer protein in vitamin E-treated methionine-choline deficient rats was significantly repressed compared to methionine-choline deficient rats. The expression of liver cytochrome P450 4F2 and ATP-binding cassette transporter protein 1, involved in metabolism and transport of alpha-tocopherol, respectively, was significantly repressed in vitamin E-treated methionine-choline deficient rats. In methionine-choline deficient rats, vitamin E treatment altered the hepatic alpha-tocopherol-related protein expression, which may affect alpha-tocopherol status in the liver, leading to reduced lipid peroxidation.
- 1 January 2013
- Published by Center for Academic Publications Japan in Journal of Nutritional Science and Vitaminology
- Vol. 59 (1) , 64-68
^|^alpha;-Tocopherol Status and Expression of ^|^alpha;-Tocopherol Transfer Protein in Type 2 Diabetic Goto-Kakizaki Rats
Vitamin E, a critical fat-soluble vitamin antioxidant, is expressed on cell membranes and prevents propagation of lipid peroxidation. alpha-Tocopherol transfer protein (alpha-TTP) is a cytosolic protein located in the hepatocytes that acts as the principal regulator of the circulating alpha-tocopherol levels. Type 2 diabetes is a metabolic disorder characterized by hyperglycemia, caused by insulin resistance. Lipid peroxidation promotes the clinical progression and development of complications in type 2 diabetes. Results of animal and human experiments on the vitamin E status in diabetes are conflicting. The present study was conducted with the objective of investigating the vitamin E status and alpha-TTP expression in Goto-Kakizaki (GK) rats, a model of type 2 diabetes. In diabetic GK rats, increases of the alpha-tocopherol levels in the plasma and liver were observed as compared with the levels in the controls. No alternation in the CuZn-superoxide dismutase (SOD) or Mn-SOD gene expression was found in the liver of GK rats as compared with that in the controls. The GK rats showed an increase of the hepatic expression of the alpha-TTP gene as compared with the level in the controls. It can be suggested that the increased hepatic alpha-TTP gene expression levels may influence plasma alpha-tocopherol levels in the diabetic animals. Hence, investigation of the regulatory factors of alpha-TTP expression may provide important clues to highlighting the antioxidant mechanisms of vitamin E.
- 1 January 2013
- Published by Center for Academic Publications Japan in Journal of Nutritional Science and Vitaminology
- Vol. 59 (1) , 64-68
^|^alpha;-Tocopherol Status and Expression of ^|^alpha;-Tocopherol Transfer Protein in Type 2 Diabetic Goto-Kakizaki Rats
Vitamin E, a critical fat-soluble vitamin antioxidant, is expressed on cell membranes and prevents propagation of lipid peroxidation. alpha-Tocopherol transfer protein (alpha-TTP) is a cytosolic protein located in the hepatocytes that acts as the principal regulator of the circulating alpha-tocopherol levels. Type 2 diabetes is a metabolic disorder characterized by hyperglycemia, caused by insulin resistance. Lipid peroxidation promotes the clinical progression and development of complications in type 2 diabetes. Results of animal and human experiments on the vitamin E status in diabetes are conflicting. The present study was conducted with the objective of investigating the vitamin E status and alpha-TTP expression in Goto-Kakizaki (GK) rats, a model of type 2 diabetes. In diabetic GK rats, increases of the alpha-tocopherol levels in the plasma and liver were observed as compared with the levels in the controls. No alternation in the CuZn-superoxide dismutase (SOD) or Mn-SOD gene expression was found in the liver of GK rats as compared with that in the controls. The GK rats showed an increase of the hepatic expression of the alpha-TTP gene as compared with the level in the controls. It can be suggested that the increased hepatic alpha-TTP gene expression levels may influence plasma alpha-tocopherol levels in the diabetic animals. Hence, investigation of the regulatory factors of alpha-TTP expression may provide important clues to highlighting the antioxidant mechanisms of vitamin E.
- 1 January 2011
- Published by Center for Academic Publications Japan in Journal of Nutritional Science and Vitaminology
- Vol. 57 (1) , 108-113
Altered Expression of Both β-Carotene 15,15' Monooxygenase and Lecithin:Retinol Acyltransferase in Obese Zucker Rats
Japan's largest platform for academic e-journals: J-STAGE is a full text database for reviewed academic papers published by Japanese societies
- 1 January 2011
- Published by Center for Academic Publications Japan in Journal of Nutritional Science and Vitaminology
- Vol. 57 (1) , 108-113
Altered Expression of Both β-Carotene 15,15' Monooxygenase and Lecithin:Retinol Acyltransferase in Obese Zucker Rats
Japan's largest platform for academic e-journals: J-STAGE is a full text database for reviewed academic papers published by Japanese societies
- Open Access
- 1 January 2009
- Published by Japanese Society of Toxicology in The Journal of Toxicological Sciences
- Vol. 34 (Special 2) , SP223-SP228
Children's toxicology from bench to bed - Liver Injury (2): Mechanism of antioxidant therapy for nonalcoholic fatty liver disease
Japan's largest platform for academic e-journals: J-STAGE is a full text database for reviewed academic papers published by Japanese societies
- 1 January 2009
- Published by Japanese Society of Toxicology in The Journal of Toxicological Sciences
- Vol. 34 (Special 2) , SP223-SP228
Open AccessChildren's toxicology from bench to bed - Liver Injury (2): Mechanism of antioxidant therapy for nonalcoholic fatty liver disease
Japan's largest platform for academic e-journals: J-STAGE is a full text database for reviewed academic papers published by Japanese societies
- 1 January 2008
- Published by Wiley in BioFactors
- Vol. 33 (1) , 77-83
Expression of ß‐carotene 15,15′‐monooxygenase gene and retinol status in type 2 diabetic Goto‐kakizaki rats
The vitamin A status has been studied in type 2 diabetes and it is known that plasma retinol levels of patients with type 2 diabetes are elevated. However, the details of vitamin A metabolism in type 2 diabetes are unclear. ß-Carotene exhibits biological activity as provitamin A and ß-carotene 15,15′-monooxygenase (BCM) cleaves ß-carotene to form retinal. We studied BCM gene expression in type 2 diabetic Goto-Kakizaki (GK) rats. BCM gene expression was analyzed in the liver, intestine, and testis of 8- and 13-week-old GK rats and Wistar rats (control). The plasma and liver retinol levels were measured, and plasma retinol-binding protein (RBP) was detected. BCM gene expression in the liver, intestine and testis of GK rats was increased compared with that in controls. Plasma retinol levels and RBP levels were increased in GK rats, but hepatic retinol levels did not differ between GK rats and controls. BCM gene expression in the liver and intestine might affect retinol levels in type 2 diabetes. Conversion of ß-carotene to retinal might be accelerated in the presence of insulin resistance status, so that plasma retinol levels are increased in type 2 diabetes.
- 1 January 2008
- Published by Wiley in BioFactors
- Vol. 33 (1) , 77-83
Expression of ß‐carotene 15,15′‐monooxygenase gene and retinol status in type 2 diabetic Goto‐kakizaki rats
The vitamin A status has been studied in type 2 diabetes and it is known that plasma retinol levels of patients with type 2 diabetes are elevated. However, the details of vitamin A metabolism in type 2 diabetes are unclear. ß-Carotene exhibits biological activity as provitamin A and ß-carotene 15,15′-monooxygenase (BCM) cleaves ß-carotene to form retinal. We studied BCM gene expression in type 2 diabetic Goto-Kakizaki (GK) rats. BCM gene expression was analyzed in the liver, intestine, and testis of 8- and 13-week-old GK rats and Wistar rats (control). The plasma and liver retinol levels were measured, and plasma retinol-binding protein (RBP) was detected. BCM gene expression in the liver, intestine and testis of GK rats was increased compared with that in controls. Plasma retinol levels and RBP levels were increased in GK rats, but hepatic retinol levels did not differ between GK rats and controls. BCM gene expression in the liver and intestine might affect retinol levels in type 2 diabetes. Conversion of ß-carotene to retinal might be accelerated in the presence of insulin resistance status, so that plasma retinol levels are increased in type 2 diabetes.
- 13 May 2006
- Published by Springer Nature in European Journal of Nutrition
- Vol. 45 (6) , 320-326
Molecular cloning of the rat β-carotene 15,15′-monooxygenase gene and its regulation by retinoic acid
Summary Background β-Carotene exhibits biological activity as provitamin A. Key step in vitamin A formation is the cleavage of β-carotene to retinal by an enzyme designated as β-carotene 15,15′-monooxygenase (BCM). Recently, it is reported that expression of BCM gene in the intestine is under feedback regulation by retinoic acid (RA). However, the regulation of BCM gene expression in various other tissues is still unknown. Aim of the study In the present study, we identified the full-length cDNA encoding the rat BCM gene and investigated the regulation of its expression in several tissues by RA in the presence of vitamin A deficiency. Methods We cloned the full-length cDNA encoding BCM gene from a rat intestinal cDNA library by hybridization screening. The BCM gene expression was examined using Northern blotting and reverse transcription-PCR analysis. We also investigated whether BCM gene expression was regulated by retinoids in several tissues of vitamin A-deficient rats. Results Sequence analysis of this clone revealed an open reading frame of 1,701 bases encoding a protein of 566 amino acids. The predicted polypeptide showed 94%, 81%, and 66% identity with mouse, human, and chicken BCM, respectively. Rat BCM mRNA was highly expressed in the intestine and liver, while there was weak expression in the testes, kidneys, and lungs. Immunoblotting revealed that rat BCM is a 64-kDa protein. BCM gene expression was increased in the small intestine by vitamin A deficiency compared with that in rats on a control diet, while this upregulation was suppressed by all-trans RA (ATRA) or 9-cis RA (9-cis RA). BCM gene expression in the lungs and testes was also suppressed by ATRA or 9-cis RA in rats with vitamin A deficiency. However, hepatic BCM gene expression was only decreased by ATRA and renal expression was not affected by either retinoid. As the small intestine is the major site of β-carotene conversion, intestinal BCM gene expression may be more tightly regulated. Conclusion These data suggest that BCM gene expression in several tissues may be down-regulated by RA at the level of conversion of β-carotene to retinal. To prevent an excess of retinol, homeostasis may occur at the level of conversion of β-carotene to retinal in several tissues.
- 13 May 2006
- Published by Springer Nature in European Journal of Nutrition
- Vol. 45 (6) , 320-326
Molecular cloning of the rat β-carotene 15,15′-monooxygenase gene and its regulation by retinoic acid
Summary Background β-Carotene exhibits biological activity as provitamin A. Key step in vitamin A formation is the cleavage of β-carotene to retinal by an enzyme designated as β-carotene 15,15′-monooxygenase (BCM). Recently, it is reported that expression of BCM gene in the intestine is under feedback regulation by retinoic acid (RA). However, the regulation of BCM gene expression in various other tissues is still unknown. Aim of the study In the present study, we identified the full-length cDNA encoding the rat BCM gene and investigated the regulation of its expression in several tissues by RA in the presence of vitamin A deficiency. Methods We cloned the full-length cDNA encoding BCM gene from a rat intestinal cDNA library by hybridization screening. The BCM gene expression was examined using Northern blotting and reverse transcription-PCR analysis. We also investigated whether BCM gene expression was regulated by retinoids in several tissues of vitamin A-deficient rats. Results Sequence analysis of this clone revealed an open reading frame of 1,701 bases encoding a protein of 566 amino acids. The predicted polypeptide showed 94%, 81%, and 66% identity with mouse, human, and chicken BCM, respectively. Rat BCM mRNA was highly expressed in the intestine and liver, while there was weak expression in the testes, kidneys, and lungs. Immunoblotting revealed that rat BCM is a 64-kDa protein. BCM gene expression was increased in the small intestine by vitamin A deficiency compared with that in rats on a control diet, while this upregulation was suppressed by all-trans RA (ATRA) or 9-cis RA (9-cis RA). BCM gene expression in the lungs and testes was also suppressed by ATRA or 9-cis RA in rats with vitamin A deficiency. However, hepatic BCM gene expression was only decreased by ATRA and renal expression was not affected by either retinoid. As the small intestine is the major site of β-carotene conversion, intestinal BCM gene expression may be more tightly regulated. Conclusion These data suggest that BCM gene expression in several tissues may be down-regulated by RA at the level of conversion of β-carotene to retinal. To prevent an excess of retinol, homeostasis may occur at the level of conversion of β-carotene to retinal in several tissues.
- 1 October 2005
- Published by S. Karger AG in Acta Haematologica
- Vol. 114 (3) , 167-169
Plasma All-Trans Retinoic Acid Level in Neonates of Mothers with Acute Promyelocytic Leukemia
- 1 October 2005
- Published by S. Karger AG in Acta Haematologica
- Vol. 114 (3) , 167-169
Plasma All-Trans Retinoic Acid Level in Neonates of Mothers with Acute Promyelocytic Leukemia